A Study of K-645 in the Treatment of Multiple Migraine Attacks

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the treatment of patients with acute migraine.

Timeline

Start

2025-08-12

Primary completion

2025-11-07

Completion

2025-11-07

Outcome

Outcome not reported

Stopped: “Study stopped for futility based on an interim analysis of efficacy.”

Drugs

Indications